Patients with end stage renal disease (GFR <15mL/min/1.73m 2): maximum daily dose is 30 mg. Administration of 60 mg Vyvanse chewable tablet with food (a high-fat meal) decreases the exposure (C ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

Lisdexamfetamine dimesylate (Vyvanse; New River Pharmaceuticals ... dose treatment groups that received final doses of 30, 50 or 70 mg of lisdexamfetamine dimesylate (as a capsule) or placebo ...

30 mg, 40 mg, 50 mg, and 60 mg. The approved ANDA has been deemed bioequivalent, or therapeutically equivalent (AB Rating), to the reference listed drug (RLD), Vyvanse chewable tablets ...